USPTO serial 79213961
HALIOSEEK
Reviewed by CopyMark Law Group
Reg. 5592381Status 709
- Filing date
- Status date
- Registration date
- Oct 30, 2018
- Examiner
- BROOKSHIRE, DAVID AARON
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with HALIOSEEK?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kevin A. Thompson
Kevin A. Thompson LADAS & PARRY LLP224 South Michigan AvenueSuite 1600Chicago, IL 60604Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for use in vitro testing, for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; chemical preparations for medical and pharmaceutical use for use in vitro testing, for use in the clinical diagnostic, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; biological reagents for medical use for providing information on diagnostics or identification of biological systems; biological reagents for medical use providing information on diagnostics or identification of biological systems; immunological reagents for medical use; biological reagents for medical diagnosis; medical diagnostic kits comprising reagents and assays for testing tissue samples; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosis | SECTION 71 - CANCELLED | — |
| 009 | Software for use in the clinical diagnosis, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition; application software in the field of biology for use in the clinical diagnostic, prognosis, monitoring, prediction of response to treatments and on-going evaluation, analysis and study of a cancer, tumor or equivalent medical condition | SECTION 71 - CANCELLED | — |
| 010 | Medical apparatus, instruments and equipment for medical analysis, namely autostainers, scanners; medical apparatus and instruments for providing information on diagnostics or identification of biological systems, namely, medical testing devices and diagnostic apparatus for detecting, analysing or assessing a cancer, tumor or equivalent medical condition; medical instruments for cancer cell detection | SECTION 71 - CANCELLED | — |
| 042 | Scientific research and development; clinical trial services, namely, intervening in the process of clinical trial services in assessment of biomarkers or signatures; tests in laboratories, namely analysis of biological mechanisms of actions, biomarkers and signatures for research in biology purposes; development of quality control testing methods for others; research, development, technical design, testing, consultancy and analysis services in the field of immunology; research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the field of genome and immune index analysis; design and development of software in the field of biology | SECTION 71 - CANCELLED | — |
| 044 | Medical analysis services, namely, analysis of tumor, cancer or equivalent medical condition; medical assistance; heath care services; medical therapeutic services; medical diagnostics, diagnostics in the field of medicine; genetic analysis services for medical purposes | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HalioDx
- Other trademarks owned by HalioDx
- Other trademarks owned by Veracyte
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named HALIOSEEK
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 20, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 20, 2026 | INPC | INVALIDATION PROCESSED | — |
| Jan 16, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Aug 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 16, 2025 | C71T | CANCELLED SECTION 71 | — |
| Oct 30, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Feb 12, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 1, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 7, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 7, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 30, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 30, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 14, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 14, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 11, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 25, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 25, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 25, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 10, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 23, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 13, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 3, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 3, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 21, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 19, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 12, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 9, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 19, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 18, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 18, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 17, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 16, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 15, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |